Pfizer, BioNTech to supply EU with 200 million doses of mRNA-based vaccine candidate against SARS-CoV-2

Pfizer, BioNTech to supply EU with 200 million doses of mRNA-based vaccine candidate against SARS-CoV-2. (Credit: Gerd Altmann from Pixabay)